Boston Scientific makes devices for heart procedures — stents, ablation tools, pacemakers.
Boston Scientific Corporation (BSX) is expected to report earnings on Wednesday, October 28, 2026, before the open. Estimated release time 06:33 ET. Consensus EPS estimate is $0.75.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $0.83 | $0.86 | +3.0% | $5.44B |
| 2026-04-22 | Mar 2026 qtr | $0.79 | $0.80 | +1.5% | $5.20B |
| 2026-02-04 | Dec 2025 qtr | $0.78 | $0.80 | +2.4% | $5.29B |
| 2025-10-22 | Sep 2025 qtr | $0.71 | $0.75 | +5.0% | $5.07B |
| 2025-07-23 | Jun 2025 qtr | $0.72 | $0.75 | +3.4% | $5.06B |
| 2025-04-23 | Mar 2025 qtr | $0.67 | $0.75 | +11.4% | $4.66B |
| 2025-02-05 | Dec 2024 qtr | $0.66 | $0.70 | +6.5% | $4.56B |
| 2024-10-23 | Sep 2024 qtr | $0.59 | $0.63 | +7.1% | $4.21B |
BSX has beaten consensus EPS in 8 of its last 8 scored quarters.
See BSX on the live calendar →